The Role of Circulating Tumor Cells in Breast Cancer and Implications for Radiation Treatment Decisions.

Volume: 109, Issue: 1, Pages: 44 - 59
Published: Jan 1, 2021
Abstract
Tumor biomarkers are used routinely in oncology to assign risk categorization, screen and assist in diagnosis of malignancy, allow for prognostication and prediction of outcomes and treatment response, and allow for monitoring of patients after treatment completion. Although tissue-based biomarkers have a long history of use, the emergence of liquid-based biomarkers, including circulating tumor cells (CTCs), may soon revolutionize the management...
Paper Details
Title
The Role of Circulating Tumor Cells in Breast Cancer and Implications for Radiation Treatment Decisions.
Published Date
Jan 1, 2021
Volume
109
Issue
1
Pages
44 - 59
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.